These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26358110)

  • 1. Joseph C. Wu: Envisioning Personalized Medicine and Clinical Trials in a Dish.
    Ince S; Wu JC
    Circ Res; 2015 Sep; 117(7):599-602. PubMed ID: 26358110
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine: Time for one-person trials.
    Schork NJ
    Nature; 2015 Apr; 520(7549):609-11. PubMed ID: 25925459
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.
    Dreyling M; Ferrero S;
    Haematologica; 2015 Jun; 100(6):706-8. PubMed ID: 26034112
    [No Abstract]   [Full Text] [Related]  

  • 5. Ready or not: personalized medicine is coming. IEEE Pulse talks with Michael Snyder about its potential.
    Snyder M; Mertz L
    IEEE Pulse; 2014; 5(3):45-7. PubMed ID: 24838211
    [No Abstract]   [Full Text] [Related]  

  • 6. The computable cell: A step toward personalized medicine.
    Gough NR
    Sci Signal; 2015 Dec; 8(408):eg6. PubMed ID: 26696628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era.
    Gurtu V; Michelakis ED
    Circ Res; 2016 Dec; 119(12):1276-1279. PubMed ID: 27932471
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistical pitfalls of personalized medicine.
    Senn S
    Nature; 2018 Nov; 563(7733):619-621. PubMed ID: 30482931
    [No Abstract]   [Full Text] [Related]  

  • 9. When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
    Verschraegen CF; Rehman H; Pulluri B; DeKay J; Barry M; Folefac E; Dittus K; Holmes C; Sprague J; Ades S; Gibson PC
    Oncology; 2017; 92(1):55-60. PubMed ID: 27820931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
    Li M; Yu T; Hu YF
    Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward individualized treatment in urologic oncology.
    Rini BI
    Urol Oncol; 2015 Apr; 33(4):170. PubMed ID: 25661236
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized medicine in cancer: where are we today?
    Turnbull AK
    Future Oncol; 2015; 11(20):2795-8. PubMed ID: 26344657
    [No Abstract]   [Full Text] [Related]  

  • 13. Developing the Scientific Infrastructure to Produce Ethnogenetically-Specific Personalized Medicine.
    Ehrlich GD
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):465-6. PubMed ID: 26308678
    [No Abstract]   [Full Text] [Related]  

  • 14. [What of "personalized medicine" is really the name?].
    Nau JY
    Rev Med Suisse; 2015 Oct; 11(489):1868-9. PubMed ID: 26638521
    [No Abstract]   [Full Text] [Related]  

  • 15. Does personalized medicine exist and can you test it in a clinical trial?
    Sandercock PA
    Int J Stroke; 2015 Oct; 10(7):994-9. PubMed ID: 26282857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine initiative.
    Porche DJ
    Am J Mens Health; 2015 May; 9(3):177. PubMed ID: 25759367
    [No Abstract]   [Full Text] [Related]  

  • 17. Myeloproliferative neoplasms and personalized medicine: the perfect match?
    Kiladjian JJ; Harrison C
    Haematologica; 2015 Dec; 100(12):1493-4. PubMed ID: 26628630
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-derived tumour models for personalized therapeutics in urological cancers.
    van de Merbel AF; van der Horst G; van der Pluijm G
    Nat Rev Urol; 2021 Jan; 18(1):33-45. PubMed ID: 33173206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operationalizing Precision Cardiovascular Medicine: Three Innovations.
    Wang JJ; Aboulhosn JA; Hofer IS; Mahajan A; Wang Y; Vondriska TM
    Circ Res; 2016 Oct; 119(9):984-987. PubMed ID: 27737942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.